Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders

Marie Brandt; Jens Cardinale; Carolina Giammei; Xabier Guarrochena; Barbara Happl; Nedra Jouini; Thomas L. Mindt

doi:10.1016/j.nucmedbio.2019.01.006

Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders

Marie Brandt
, Jens Cardinale
, Carolina Giammei
, Xabier Guarrochena
, Barbara Happl
, Nedra Jouini
, Thomas L. Mindt (Corresponding author)

Department of Inorganic Chemistry

Publications: Contribution to journal › Review › Peer Reviewed

Original language	English
Pages (from-to)	46-52
Number of pages	7
Journal	Nuclear Medicine and Biology
Volume	70
DOIs	https://doi.org/10.1016/j.nucmedbio.2019.01.006
Publication status	Published - Mar 2019

Funding

This work was supported by the Austrian Science Fund (FVVF project Nr. 31477-B28) and the Swiss National Science Foundation (SNSF project Nr. 205321-157216). We thank Katarina Bencurova (Ludwig Boltzmann Institute Applied Diagnostics, Vienna) for technical assistance.

Austrian Fields of Science 2012

301207 Pharmaceutical chemistry
302054 Nuclear medicine

Keywords

Human serum albumin
Albumin binder
Targeted radiopharmaceuticals
Blood circulation time
Dual-targeted radioconjugates
Endoradiotherapy
BINDING LIGANDS
SERUM-ALBUMIN
TUMOR-THERAPY
IN-VITRO
PHARMACOKINETICS
RADIOLIGANDS
INHIBITORS
CONJUGATE
CLICK

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.nucmedbio.2019.01.006

https://phaidra.univie.ac.at/o:2066490Licence: CC BY-NC-ND 4.0

Cite this

@article{2febb1f725424bdf9bb61342b83ac97f,

title = "Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders",

keywords = "Human serum albumin, Albumin binder, Targeted radiopharmaceuticals, Blood circulation time, Dual-targeted radioconjugates, Endoradiotherapy, BINDING LIGANDS, SERUM-ALBUMIN, TUMOR-THERAPY, IN-VITRO, PHARMACOKINETICS, RADIOLIGANDS, INHIBITORS, CONJUGATE, CLICK",

author = "Marie Brandt and Jens Cardinale and Carolina Giammei and Xabier Guarrochena and Barbara Happl and Nedra Jouini and Mindt, \{Thomas L.\}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = mar,

doi = "10.1016/j.nucmedbio.2019.01.006",

language = "English",

volume = "70",

pages = "46--52",

journal = "Nuclear Medicine and Biology",

issn = "0969-8051",

publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",

}

TY - JOUR

T1 - Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders

AU - Brandt, Marie

AU - Cardinale, Jens

AU - Giammei, Carolina

AU - Guarrochena, Xabier

AU - Happl, Barbara

AU - Jouini, Nedra

AU - Mindt, Thomas L.

PY - 2019/3

Y1 - 2019/3

KW - Human serum albumin

KW - Albumin binder

KW - Targeted radiopharmaceuticals

KW - Blood circulation time

KW - Dual-targeted radioconjugates

KW - Endoradiotherapy

KW - BINDING LIGANDS

KW - SERUM-ALBUMIN

KW - TUMOR-THERAPY

KW - IN-VITRO

KW - PHARMACOKINETICS

KW - RADIOLIGANDS

KW - INHIBITORS

KW - CONJUGATE

KW - CLICK

UR - https://www.scopus.com/pages/publications/85062242378

U2 - 10.1016/j.nucmedbio.2019.01.006

DO - 10.1016/j.nucmedbio.2019.01.006

M3 - Review

SN - 0969-8051

VL - 70

SP - 46

EP - 52

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

ER -

Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders

Funding

Austrian Fields of Science 2012

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this